Journey Medical Corporation (DERM) vs Yarrow Bioscience Inc (YARW)

A side-by-side comparison of Journey Medical Corporation and Yarrow Bioscience Inc across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — DERM vs YARW

growth of $100 · dividends reinvested · last 5y
DERM -29.6% (-6.8%/yr)YARW -97.0% (-50.4%/yr)DERM compounded faster over this window
Log scale — wide-divergence pair
110100Start $10020222023202420252026$70$3
DERM YARW

DERM vs YARW: by the numbers

  • •YARW is the larger company ($178M vs $173M market cap).
  • •Both run net losses; DERM's is the smaller (-8.95% vs -3881.54% net margin).
  • •DERM grew revenue faster over the past five years (6.75% vs -43.10% CAGR).
  • •YARW pays a dividend (105.68% yield), while DERM has no payments in the available dividend history.

Metrics side by side

Valuation

MetricDERMYARW
P/S ratio2.53370.05
P/B ratio5.378.08
EV / EBITDA136.69N/A

Profitability

MetricDERMYARW
Gross margin62.24%97.51%
Operating margin-13.21%-5219.12%
Net margin-8.95%-3881.54%
ROE-19.01%-84.80%
ROIC-5.22%-90.33%

Dividends

MetricDERMYARW
Dividend yieldN/A105.68%

Growth (annualized)

MetricDERMYARW
Revenue CAGR (5Y)6.75%-43.10%
Total return CAGR (5Y)N/A-49.18%

Frequently asked

Which has grown faster, DERM or YARW?
Over the past five years, DERM grew revenue faster — DERM at a 6.75% CAGR versus YARW at -43.10%.
Does DERM or YARW pay a bigger dividend?
YARW pays a dividend (105.68% yield), while DERM has no payments in the available dividend history.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.